Details
Stereochemistry | RACEMIC |
Molecular Formula | C12H15NO3 |
Molecular Weight | 221.2524 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(NC)C(=O)C1=CC=C2OCOC2=C1
InChI
InChIKey=CGKQZIULZRXRRJ-UHFFFAOYSA-N
InChI=1S/C12H15NO3/c1-3-9(13-2)12(14)8-4-5-10-11(6-8)16-7-15-10/h4-6,9,13H,3,7H2,1-2H3
Molecular Formula | C12H15NO3 |
Molecular Weight | 221.2524 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:16:52 GMT 2023
by
admin
on
Sat Dec 16 10:16:52 GMT 2023
|
Record UNII |
X72T4EQ4FQ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Butylone
Created by
admin on Sat Dec 16 10:16:52 GMT 2023 , Edited by admin on Sat Dec 16 10:16:52 GMT 2023
|
||
|
DEA NO. |
7541
Created by
admin on Sat Dec 16 10:16:52 GMT 2023 , Edited by admin on Sat Dec 16 10:16:52 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
802575-11-7
Created by
admin on Sat Dec 16 10:16:52 GMT 2023 , Edited by admin on Sat Dec 16 10:16:52 GMT 2023
|
PRIMARY | |||
|
BUTYLONE
Created by
admin on Sat Dec 16 10:16:52 GMT 2023 , Edited by admin on Sat Dec 16 10:16:52 GMT 2023
|
PRIMARY | |||
|
56843046
Created by
admin on Sat Dec 16 10:16:52 GMT 2023 , Edited by admin on Sat Dec 16 10:16:52 GMT 2023
|
PRIMARY | |||
|
17762-90-2
Created by
admin on Sat Dec 16 10:16:52 GMT 2023 , Edited by admin on Sat Dec 16 10:16:52 GMT 2023
|
GENERIC (FAMILY) | |||
|
X72T4EQ4FQ
Created by
admin on Sat Dec 16 10:16:52 GMT 2023 , Edited by admin on Sat Dec 16 10:16:52 GMT 2023
|
PRIMARY | |||
|
100000177570
Created by
admin on Sat Dec 16 10:16:52 GMT 2023 , Edited by admin on Sat Dec 16 10:16:52 GMT 2023
|
PRIMARY | |||
|
DTXSID001024651
Created by
admin on Sat Dec 16 10:16:52 GMT 2023 , Edited by admin on Sat Dec 16 10:16:52 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> SUBSTRATE |
INDUCES SEROTONIN RELEASE; NOT A DAT SUBSTRATE
EC50
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
IC50
|
||
|
TARGET -> INHIBITOR |
HEK-293 cells stably expressing DAT
IC50
|
||
|
TARGET -> INHIBITOR |
IC50
|
||
|
TARGET -> INHIBITOR |
HEK-293 cells stably expressing SERT
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
abuser A: ND (45, after hydrolysis) mcg/mL; abuser B: ND (2.0, after hydrolysis) mcg/mL
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
abuser A: 23[31]* (27[32]*, after hydrolysis) mcg/mL; abuser B: 19[2.0]* (17[2.0]*, after hydrolysis) mcg/mL; *diastereomer
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
abuser A: 3.5 mcg/mL (6.7 mcg/mL after hydrolysis); abuser B: not quantitated (before and after hydrolysis)
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
abuser A: 3.3 (64, after hydrolysis) mcg/mL; abuser B: not quantitated (3.2, after hydrolysis) mcg/mL
IN-VIVO
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|